Home > Publications database > Precision treatment in advanced hepatocellular carcinoma > print

001     288065
005     20250820131902.0
024 7 _ |a 10.1016/j.ccell.2024.01.007
|2 doi
024 7 _ |a 1535-6108
|2 ISSN
024 7 _ |a 1878-3686
|2 ISSN
024 7 _ |a altmetric:159478418
|2 altmetric
024 7 _ |a pmid:38350421
|2 pmid
037 _ _ |a DKFZ-2024-00323
082 _ _ |a 610
100 1 _ |a Yang, Xupeng
|b 0
245 _ _ |a Precision treatment in advanced hepatocellular carcinoma
260 _ _ |a New York, NY
|c 2024
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1707825270_10362
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Yang, Chen
|0 P:(DE-He78)8b693edfb7c78bb156cc92812eec1c55
|b 1
|u dkfz
700 1 _ |a Zhang, Shu
|b 2
700 1 _ |a Geng, Haigang
|b 3
700 1 _ |a Zhu, Andrew X.
|b 4
700 1 _ |a Bernards, René
|b 5
700 1 _ |a Qin, Wenxin
|b 6
700 1 _ |a Fan, Jia
|b 7
700 1 _ |a Wang, Cun
|b 8
700 1 _ |a Gao, Qiang
|b 9
773 _ _ |a 10.1016/j.ccell.2024.01.007
|g Vol. 42, no. 2, p. 180 - 197
|0 PERI:(DE-600)2074034-7
|n 2
|p 180 - 197
|t Cancer cell
|v 42
|y 2024
|x 1535-6108
856 4 _ |u https://inrepo02.dkfz.de/record/288065/files/1-s2.0-S1535610824000126-main.pdf
856 4 _ |u https://inrepo02.dkfz.de/record/288065/files/1-s2.0-S1535610824000126-main.pdf?subformat=pdfa
|x pdfa
909 C O |o oai:inrepo02.dkfz.de:288065
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)8b693edfb7c78bb156cc92812eec1c55
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2024
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER CELL : 2022
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-24
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-24
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-24
915 _ _ |a IF >= 50
|0 StatID:(DE-HGF)9950
|2 StatID
|b CANCER CELL : 2022
|d 2023-10-24
920 1 _ |0 I:(DE-He78)D250-20160331
|k D250
|l NWG Krebs-Immunregulation
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D250-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21